Advancements in precision oncology have led to the development of life-changing, novel treatment modalities in the clinical trial setting. However, significant disparities persist in who benefits from these treatments. Public health has established core principles to ensure equitable access to care for all. How can the clinical trial landscape benefit by applying these public health principles to ensure equitable access to clinical trials? This session will explore the role of social determinants of health and provide a foundational framework for integrating community-based participatory research (CBPR) into current research projects. Participants will learn strategies to improve patient engagement and outcomes through CBPR. Attendees will leave with practical examples and methods to measure the success of their health equity initiatives in clinical research.

CEU: 1.00 ACRP

Speaker:

• Rochelle Williams-Belizaire, Director, Clinical Research Collaborations, Mirati Therapeutics

Watch a Sneak Peek into the Session Content: